Differentiation of IL-17-producing effector and regulatory human t cells from lineage-committed naive precursors

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1047-1054

  Mercer, Frances ^a   Khaitan, Alka ^a   Kozhaya, Lina ^a   Aberg, Judith A ^a   Unutmaz, Derya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR HELIOS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LINEAGE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VIRUS LOAD;

ADULT; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; FETAL BLOOD; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFANT, NEWBORN; INTERLEUKIN-17; PROTEIN PRECURSORS; RECEPTORS, CCR6; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 84906098694     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302936     Document Type: Article

References (47)

1. Ohkura, N., Y. Kitagawa, and S. Sakaguchi. 2013. Development and maintenance of regulatory T cells. Immunity 38: 414-423.
2. Mercer, F., and D. Unutmaz. 2009. The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer. Adv. Exp. Med. Biol. 665: 47-59.
3. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
4. Sallusto, F., and A. Lanzavecchia. 2009. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-2082.
5. Duhen, T., R. Duhen, A. Lanzavecchia, F. Sallusto, and D. J. Campbell. 2012. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119: 4430-4440.
6. Voo, K. S., Y. H. Wang, F. R. Santori, C. Boggiano, Y. H. Wang, K. Arima, L. Bover, S. Hanabuchi, J. Khalili, E. Marinova, et al. 2009. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 106: 4793-4798.
7. Blatner, N. R., M. F. Mulcahy, K. L. Dennis, D. Scholtens, D. J. Bentrem, J. D. Phillips, S. Ham, B. P. Sandall, M. W. Khan, D. M. Mahvi, et al. 2012. Expression of RORgt marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4: 164ra159.
8. Hovhannisyan, Z., J. Treatman, D. R. Littman, and L. Mayer. 2011. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140: 957-965.
9. Kryczek, I., K. Wu, E. Zhao, S. Wei, L. Vatan, W. Szeliga, E. Huang, J. Greenson, A. Chang, J. Rolinski, et al. 2011. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 186: 4388-4395.
10. Getnet, D., J. F. Grosso, M. V. Goldberg, T. J. Harris, H. R. Yen, T. C. Bruno, N. M. Durham, E. L. Hipkiss, K. J. Pyle, S. Wada, et al. 2010. A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells. Mol. Immunol. 47: 1595-1600.
11. Zabransky, D. J., C. J. Nirschl, N. M. Durham, B. V. Park, C. M. Ceccato, T. C. Bruno, A. J. Tam, D. Getnet, and C. G. Drake. 2012. Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 7: e34547.
12. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid, and E. M. Shevach. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184: 3433-3441.
13. Verhagen, J., and D. C. Wraith. 2010. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J. Immunol. 185: 7129.
14. Akimova, T., U. H. Beier, L.Wang, M. H. Levine, andW.W. Hancock. 2011. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6: e24226.
15. Himmel, M. E., K. G. MacDonald, R. V. Garcia, T. S. Steiner, and M. K. Levings. 2013. Helios+ and Helios2 cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J. Immunol. 190: 2001-2008.
16. Antons, A. K., R.Wang, K. Oswald-Richter, M. Tseng, C.W. Arendt, S. A. Kalams, and D. Unutmaz. 2008. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J. Immunol. 180: 764-773.
17. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962.
18. Seddiki, N., B. Santner-Nanan, S. G. Tangye, S. I. Alexander, M. Solomon, S. Lee, R. Nanan, and B. Fazekas de Saint Groth. 2006. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107: 2830-2838.
19. Wang, R., L. Kozhaya, F. Mercer, A. Khaitan, H. Fujii, and D. Unutmaz. 2009. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13439-13444.
20. Tran, D. Q., H. Ramsey, and E. M. Shevach. 2007. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-b dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
21. Hori, S. 2008. Rethinking the molecular definition of regulatory T cells. Eur. J. Immunol. 38: 928-930.
22. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R. Min, G. D. Victora, Y. Shen, J. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-b-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgt function. Nature 453: 236-240.
23. Weaver, C. T., and R. D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat. Rev. Immunol. 9: 883-889.
24. Weaver, C. T., C. O. Elson, L. A. Fouser, and J. K. Kolls. 2013. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8: 477-512.
25. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
26. Thakker, P., M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic. 2007. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178: 2589-2598.
27. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2: E198.
28. Wan, Q., L. Kozhaya, A. ElHed, R. Ramesh, T. J. Carlson, I. M. Djuretic, M. S. Sundrud, and D. Unutmaz. 2011. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J. Exp. Med. 208: 1875-1887.
29. Sugimoto, N., T. Oida, K. Hirota, K. Nakamura, T. Nomura, T. Uchiyama, and S. Sakaguchi. 2006. Foxp3-dependent and-independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18: 1197-1209.
30. Ayyoub, M., F. Deknuydt, I. Raimbaud, C. Dousset, L. Leveque, G. Bioley, and D. Valmori. 2009. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORgt. Proc. Natl. Acad. Sci. USA 106: 8635-8640.
31. Valmori, D., C. Raffin, I. Raimbaud, and M. Ayyoub. 2010. Human RORgt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc. Natl. Acad. Sci. USA 107: 19402-19407.
32. Wang, R., Q. Wan, L. Kozhaya, H. Fujii, and D. Unutmaz. 2008. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 3: e2705.
33. Shevach, E. M., D. Q. Tran, T. S. Davidson, and J. Andersson. 2008. The critical contribution of TGF-b to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38: 915-917.
34. Raffin, C., I. Raimbaud, D. Valmori, and M. Ayyoub. 2011. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells. J. Immunol. 187: 5196-5202.
35. Afzali, B., P. J. Mitchell, F. C. Edozie, G. A. Povoleri, S. E. Dowson, L. Demandt, G. Walter, J. B. Canavan, C. Scotta, B. Menon, et al. 2013. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur. J. Immunol. 43: 2043-2054.
36. Pesenacker, A. M., D. Bending, S. Ursu, Q. Wu, K. Nistala, and L. R. Wedderburn. 2013. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121: 2647-2658.
37. Tran, D. Q., J. Andersson, D. Hardwick, L. Bebris, G. G. Illei, and E. M. Shevach. 2009. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
38. Mercer, F., L. Kozhaya, and D. Unutmaz. 2010. Expression and function of TNF and IL-1 receptors on human regulatory T cells. PLoS ONE 5: e8639.
39. Douek, D. 2007. HIV disease progression: immune activation, microbes, and a leaky gut. Top. HIV Med. 15: 114-117.
40. Kanwar, B., D. Favre, and J. M. McCune. 2010. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr. Opin. HIV AIDS 5: 151-157.
41. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1b and 6 but not transforming growth factor-b are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
42. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human TH-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORgt. Nat. Immunol. 9: 641-649.
43. Zielinski, C. E., F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto. 2012. Pathogeninduced human TH17 cells produce IFN-g or IL-10 and are regulated by IL-1b. Nature 484: 514-518.
44. Marks, B. R., H. N. Nowyhed, J. Y. Choi, A. C. Poholek, J. M. Odegard, R. A. Flavell, and J. Craft. 2009. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 10: 1125-1132.
45. Beriou, G., C. M. Costantino, C.W. Ashley, L. Yang, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler. 2009. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113: 4240-4249.
46. Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110: 55-62.
47. Medzhitov, R., D. S. Schneider, and M. P. Soares. 2012. Disease tolerance as a defense strategy. Science 335: 936-941.